The Purpose of This Study is to Evaluate the Efficacy and Safety of Aficamten (CK-3773274) Compared to Placebo in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

The Purpose of This Study is to Evaluate the Efficacy and Safety of Aficamten (CK-3773274) Compared to Placebo in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Conditions: Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Interventions: Drug: Aficamten; Drug: Placebo
Sponsors: Cytokinetics
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 14, 2023Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments